Search Results 1451-1460 of 18094 for multiple%20sclerosis
ABBV-383 is an investigational drug being developed for the treatment of Relapsed or Refractory Multiple Myeloma. Participation eligibility. Participant ...
July 20, 2015. Infectious Diseases. Mayo and Karolinska Seek Vaccine for Bird Flu. Community. July 20, 2015. Individualized Medicine. Secondary Genetic Findings ...
... multiple myeloma (RRMM) and refractory non ... Sclerosis Rochester, MN; Scottsdale/Phoenix, AZ; Jacksonville, FL ... 20 million cells. 20 patients (age 12 to 17 ...
The purpose of this registry called Every Child, is to collect data and biospecimens from multiple body sources for younger patients with cancer over time.
Cardiovascular. Blood clots in the heart are common in patients with COVID-19. Terri Malloy. November 20, 2020. Biotherapeutics. How COVID-19 empowered ...
February 20, 2024. Types of encephalitis: A Mayo Clinic expert explains ... February 20, 2024. Closing the clinical trials disparity gap featured image.
A Study to Evaluate TAK-981 Given With Monoclonal Antibodies In Adults With Relapsed or Refractory Multiple Myeloma ... multiple myeloma. ... 20% of cells in the ...
rehabilitation, Neuromuscular disorder, Concussion, Brain tumor, Traumatic brain injury, Multiple sclerosis, Muscular dystrophy, Myopathy, Gait disturbance ...
The primary purpose of this study is to understand the influence of sex and gender on pathophysiologic mechanisms of neurodegeneration in Multiple System ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.